Clinical studies of the modulation of Ftorafur.
Creaven
P J
PJ
Division of Investigational Therapeutics, Roswell Park Cancer Institute (RPCI), Buffalo, NY 14263.
Rustum
Y M
YM
Petrelli
N J
NJ
Gorbunova
V A
VA
D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007564:Japan; D015394:Molecular Structure; D012426:Russia; D005641:Tegafur / Q000627:therapeutic use*; D014481:United States
D007155:Immunologic Factors; D005641:Tegafur